Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of aripiprazole and risperidone in children with ADHD
IRCT2015123025768N1Phase 3Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of aripiprazole and risperidone in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Golestan University of Medical Sciences. Started May 2016; status: completed.
02
Drugs
aripiprazolerisperidone
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on IRCT2015123025768N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015123025768N1.